EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Company News
Home
>
Newsroom
>
Company News
ALL
2026
2025
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
2013
2012
2007
2026.01.05
CanSinoBIO Advances Pneumococcal Vaccine Portfolio as PCV24 Receives Clinical Trial Approval
1